These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis. Sandner AS; Weggel R; Mehraein Y; Schneider S; Hiddemann W; Spiekermann K PLoS One; 2019; 14(4):e0215453. PubMed ID: 30998723 [TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies. Wlodarska I; La Starza R; Baens M; Dierlamm J; Uyttebroeck A; Selleslag D; Francine A; Mecucci C; Hagemeijer A; Van den Berghe H; Marynen P Blood; 1998 Feb; 91(4):1399-406. PubMed ID: 9454771 [TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization analyses of hematologic malignancies reveal frequent cytogenetically unrecognized 12p rearrangements. Andreasson P; Johansson B; Billström R; Garwicz S; Mitelman F; Höglund M Leukemia; 1998 Mar; 12(3):390-400. PubMed ID: 9529134 [TBL] [Abstract][Full Text] [Related]
10. Hereditary cancer syndrome-associated pathogenic variants are common in patients with hematologic malignancies subsequent to primary solid cancer. Oh J; Kim YR; Kim Y; Kim B; Park KS; Nam SH; Lee KA J Cancer; 2021; 12(14):4288-4294. PubMed ID: 34093829 [No Abstract] [Full Text] [Related]
11. Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition. Andrés-Zayas C; Suárez-González J; Rodríguez-Macías G; Dorado N; Osorio S; Font P; Carbonell D; Chicano M; Muñiz P; Bastos M; Kwon M; Díez-Martín JL; Buño I; Martínez-Laperche C Mol Oncol; 2021 Sep; 15(9):2273-2284. PubMed ID: 33533142 [TBL] [Abstract][Full Text] [Related]
12. Heritability of hematologic malignancies: from pedigrees to genomics. Churpek JE; Onel K Hematol Oncol Clin North Am; 2010 Oct; 24(5):939-72. PubMed ID: 20816581 [TBL] [Abstract][Full Text] [Related]
13. ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations. Strehl S; Nebral K; König M; Harbott J; Strobl H; Ratei R; Struski S; Bielorai B; Lessard M; Zimmermann M; Haas OA; Izraeli S Clin Cancer Res; 2008 Feb; 14(4):977-83. PubMed ID: 18281529 [TBL] [Abstract][Full Text] [Related]
14. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia. Galera P; Dulau-Florea A; Calvo KR Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978 [TBL] [Abstract][Full Text] [Related]
15. A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature. Tirado CA; Siangchin K; Shabsovich DS; Sharifian M; Schiller G Biomark Res; 2016; 4(1):16. PubMed ID: 27570624 [TBL] [Abstract][Full Text] [Related]
16. Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies. Tosi S; Giudici G; Mosna G; Harbott J; Specchia G; Grosveld G; Privitera E; Kearney L; Biondi A; Cazzaniga G Genes Chromosomes Cancer; 1998 Mar; 21(3):223-9. PubMed ID: 9523197 [TBL] [Abstract][Full Text] [Related]
17. Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study. Moriyama T; Metzger ML; Wu G; Nishii R; Qian M; Devidas M; Yang W; Cheng C; Cao X; Quinn E; Raimondi S; Gastier-Foster JM; Raetz E; Larsen E; Martin PL; Bowman WP; Winick N; Komada Y; Wang S; Edmonson M; Xu H; Mardis E; Fulton R; Pui CH; Mullighan C; Evans WE; Zhang J; Hunger SP; Relling MV; Nichols KE; Loh ML; Yang JJ Lancet Oncol; 2015 Dec; 16(16):1659-66. PubMed ID: 26522332 [TBL] [Abstract][Full Text] [Related]
18. Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation. Kanagal-Shamanna R; Loghavi S; DiNardo CD; Medeiros LJ; Garcia-Manero G; Jabbour E; Routbort MJ; Luthra R; Bueso-Ramos CE; Khoury JD Haematologica; 2017 Oct; 102(10):1661-1670. PubMed ID: 28659335 [TBL] [Abstract][Full Text] [Related]
19. Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions. Koleilat A; McGarrah PW; Olteanu H; Van Dyke DL; Smadbeck JB; Johnson SH; Vasmatzis G; Hoppman NL; Xu X; Ketterling RP; Greipp PT; Baughn LB; Patnaik MS; Peterson JF Cancer Genet; 2022 Jan; 260-261():1-5. PubMed ID: 34781094 [TBL] [Abstract][Full Text] [Related]
20. Characterization of leukemias with ETV6-ABL1 fusion. Zaliova M; Moorman AV; Cazzaniga G; Stanulla M; Harvey RC; Roberts KG; Heatley SL; Loh ML; Konopleva M; Chen IM; Zimmermannova O; Schwab C; Smith O; Mozziconacci MJ; Chabannon C; Kim M; Frederik Falkenburg JH; Norton A; Marshall K; Haas OA; Starkova J; Stuchly J; Hunger SP; White D; Mullighan CG; Willman CL; Stary J; Trka J; Zuna J Haematologica; 2016 Sep; 101(9):1082-93. PubMed ID: 27229714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]